Cargando…
Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus
Cardiac rhabdomyoma (CRHM) is the principal cardiac tumor in children and is most often associated with tuberous sclerosis complex (TSC). Mutations in the TSC1 and TSC2 genes cause the overactivation of the mammalian Target of Rapamycin (mTOR). This protein family is responsible for abnormal cell pr...
Autores principales: | Hurtado-Sierra, Daniel, Ramos Garzón, Judy Ximena, Rojas, Lyda Z., Fernández-Gómez, Oscar, Manrique-Rincón, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975344/ https://www.ncbi.nlm.nih.gov/pubmed/36873633 http://dx.doi.org/10.3389/fped.2023.1109646 |
Ejemplares similares
-
Regression of Cardiac Rhabdomyomas in a Neonate after Everolimus Treatment
por: Bornaun, Helen, et al.
Publicado: (2016) -
Effect and Complications of Everolimus Use for Giant Cardiac Rhabdomyomas with Neonatal Tuberous Sclerosis
por: Shibata, Yuka, et al.
Publicado: (2019) -
Regression of Neonatal Cardiac Rhabdomyoma in Two Months Through Low-Dose Everolimus Therapy: A Report of Three Cases
por: Chang, Jeng-Sheng, et al.
Publicado: (2017) -
Rapid Regression of Prenatally Identified Intrapericardial Giant Rhabdomyomas with Sirolimus
por: Patel, Chandni, et al.
Publicado: (2018) -
Symptomatic improvement using everolimus in infants with cardiac rhabdomyoma
por: Dhulipudi, Bhargavi, et al.
Publicado: (2019)